Share Prices & Company Research

Stockbroking

Dechra Pharmaceuticals

Current Price 3870.00p Bid 3866.00p Ask 3870.00p Change 0.00%
Last Updated: 18/05/2025 05:10. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Financial Highlights Year Ended 30/06/2023

Revenue
£761.50m
Operating Profit/Loss
£6.30m
Dividend yield (%)
0.30
Total dividend for year
n/ap
Dividend cover
-1.97
P/E Ratio
n/a

Key Personnel

Mr Paul Sandland
CFO & Executive Director
Mr Ian Page
Chief Executive Officer
Mr Alison Platt
Non-Executive Director
Mr Geeta Gopalan
Non-Executive Director
Mr John Shipsey
Non-Executive Director
Mr Lawson Macartney
Non-Executive Director
Mr Lisa Bright
Non-Executive Director

Stock Details

EPIC
DPHL
ISIN
GB0009633180
Shares in Issue
88.09m
Market cap
£3,409.18m

Analyst Views (5)

Strong Buy
 
20.00%
Buy
 
40.00%
Hold
 
40.00%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
3,870.00p
Bid Price
3,866.00p
Ask Price
3,870.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
3,870.00p
Previous Close
3,870.00p
Intraday High
3,870.00p
Intraday Low
3,870.00p
52 Week High
3,870.00p
52 Week Low
3,870.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.